Global Cardio Oncology Registry Protocol (G-COR)
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
1. Incidence of CTRCD in Cardio-Oncology services in all participating centers. 2. Identify risk factors resulting in increased CTRCD, and validate risk score models. 3. Evaluate geographic and regional differences in use of biomarkers and imaging modalities, and its impact of management of CTRCD. 4. Evaluate impact of socioeconomic and demographic variables in access to care, utilized surveillance strategies, treatments and outcomes. 5. Describe outcomes of cancer survivors treated with different potential cardio-toxic modalities in different geographic locations. 6. Provide a platform for multiple collaborations, sub-studies and prospective clinical studies.
- New cardio-oncology consultation for breast cancer patients, or
- New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or
- New cardio-oncology consultation for acute or chronic leukemia patients, or
- New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or
- New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation.
- 18 years of age or older.
- Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators.
- Minors less than 18 years old.
- Inability or unwillingness to consent to participate.
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.